Viewing Study NCT02057250


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT02057250
Status: COMPLETED
Last Update Posted: 2017-06-20
First Post: 2014-01-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-03
Start Date Type: None
Primary Completion Date: 2015-02
Primary Completion Date Type: ACTUAL
Completion Date: 2016-03
Completion Date Type: ACTUAL
First Submit Date: 2014-01-31
First Submit QC Date: None
Study First Post Date: 2014-02-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-05-23
Results First Submit QC Date: None
Results First Post Date: 2017-06-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-12-14
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-05-23
Last Update Post Date: 2017-06-20
Last Update Post Date Type: ACTUAL